Determining the Efficacy of Brain Electrical Stimulation in Shortening the Hospitalization of Patients With drug resistant epilepsy

The Efficacy of High Definition anodal transcranial direct current stimulation in shortening of duration of hospitalization in Epilepsy Monitoring Unit of patients with drug-resistant epilepsy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200111046082N2

Enrollment

Registered

2020-04-10

Start date

2020-06-20

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

drug resistant epilepsy. Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable

Interventions

Intervention 1: Intervention group: Twenty patients diagnosed with drug-resistant epilepsy will be studied according to the definition of the International league against Epilepsy (ILAE) after approva

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with drug-resistant epilepsy as defined by the International League against epilepsy (ILAE) Over 18 years old In all patients, the probable epileptogenic zone is localized according to the epilepsy semiology and consecutive previous EEGs, and epileptogenic lesions are diagnosed by brain MRI with epilepsy protocol.

Exclusion criteria

Exclusion criteria: Under 18 years old generalized epilepsy scalp diseases such as eczema , cutaneous lesions , previous intracranial surgery previous intracranial surgery, intracranial metal (out of mouth) such as tracking, surgical clip implanted device such as cardiac pace maker, VNS, cochlear implant severe and recurrent headaches

Design outcomes

Primary

Measure	Time frame
Investigating changes in hospitalization duration in epilepsy monitoring unit. Timepoint: The frequency of epileptic seizures will be recorded in both groups for 7 days. Method of measurement: Record the number of attacks.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoheila Rezakhani Jafarabadi

Kerman University of Medical Sciences

drrezakhani@gmail.com+98 34 3226 3855

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026